Acurian Health

More variants will emerge. Let’s Be Ready.

SARS CoV 2, the virus that causes COVID, has altered (mutated) over time. The evolution in the genetic make-up of the virus has led to the emergence of variants like Delta and Omicron, both of which are highly transmissible and may be symptomless

Right now, our researchers are seeking participants to join studies for vaccine boosters that could help provide immunity against breakthrough infections. If you’ve received your primary vaccination, you may be eligible.

Together, we have the potential to help the scientific community as it strives to develop the next generation of vaccines and vaccine boosters. See if you qualify for studies today.

We’re seeking adults who meet EITHER of the following requirements: Received full primary vaccination (2 shots) for COVID-10 OR Received full primary vaccination (2 shots) for COVID-19, PLUS one (1) booster shot

People ages 65 and over are encouraged to participate!

Get started now

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

Greatly increased availability of video office visits
Ensuring social distancing measures are taken in all waiting areas
Continuing the practice of cleaning and disinfecting exam rooms thoroughly between every visit
Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.

© 2021 Acurian, Inc. All rights reserved.

*In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.

866-576-2317

Clinical Trials For A Potentially More Effective COVID-19 Vaccine Booster

Research studies are enrolling today!